S-1 maintenance therapy after induction therapy with carboplatin and albumin-bound paclitaxel in patients with advanced squamous non-small-cell lung cancer: phase II study (HSR1502)
Phase 2
- Conditions
- advanced squamous non-small-cell lung cancer
- Registration Number
- JPRN-UMIN000018428
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Fifty-one patients were enrolled in the study. The median progression-free survival from the start of maintenance therapy was 3.0 months).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 51
Inclusion Criteria
Not provided
Exclusion Criteria
1) history of pyrimidine-based chemotherapy 2) symptomatic brain metastasis (asymptomatic cases after treatments are allowed) 3) fluid retention that needs to be controlled 4) watery diarrhea 5) severe comorbidities 6) active cancers in other organs 7) existence and/or willing to pregnancy 8) psychological disorder incapable of entry for the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method